Androgen receptor variant-7: an important predictive biomarker in castrate resistant prostate cancer
The recent manuscript in New England Journal of Medicine by Antonarakis et al. [1] has important clinical implications. This study evaluates mRNA expression of a particular androgen receptor splice variant-7 (AR-V7), in circulating tumor cells (CTCs) from metastatic castrate-resistant prostate cance...
Main Authors: | Oliver Sartor, Yan Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-06-01
|
Series: | Asian Journal of Andrology |
Online Access: | http://ajandrology.com/article.asp?issn=1008-682X;year=2015;volume=17;issue=3;spage=439;epage=440;aulast=Sartor |
Similar Items
-
Androgen receptor variants occur frequently in castration resistant prostate cancer metastases.
by: Xiaotun Zhang, et al.
Published: (2011-01-01) -
Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
by: Lin Hui-Ping, et al.
Published: (2011-08-01) -
Identifying mechanisms of androgen receptor variant regulation in models of castrate resistant prostate cancer
by: Jones, Dominic Louis
Published: (2016) -
The Role of Androgen Receptor Splicing Variant 7 in Predicting the Prognosis of Metastatic Castration-Resistant Prostate Cancer: Systematic Review and Meta-Analysis
by: Rui-Ji Liu, et al.
Published: (2021-07-01) -
Commentary: Meta-Analyses Reporting the Prognostic Value of Androgen Receptor Splice Variant 7 in Castration-Resistant Prostate Cancer
by: Michael W. Kattan, et al.
Published: (2020-11-01)